Costimulation modulation with abatacept in patients with recent-onset type 1 diabetes: follow-up 1 year after cessation of treatment.

Orban T, Bundy B, Becker DJ, Dimeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Peakman M, Raskin P, Russell WE, Schatz D, Wherrett DK, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet Abatacept Study Group
Diabetes Care. 2014 37 (4): 1069-75

PMID: 24296850 · PMCID: PMC3964491 · DOI:10.2337/dc13-0604

MeSH Terms (16)

Abatacept Adolescent Adult C-Peptide Child Diabetes Mellitus, Type 1 Female Follow-Up Studies Glycated Hemoglobin A Humans Immunoconjugates Immunosuppressive Agents Male Placebos Withholding Treatment Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links